AdvaMed’s SMTA is a network of state-based industry associations including MedTech, the hub of Upstate New York’s Bio/Med industry. Building on AdvaMed’s federal-level Competitiveness Agenda launched in 2011, the association’
“America’s medical technology companies support two million jobs nationwide. The U.S. is the global leader in the development of medical technology but that leadership is eroding. And yet, there are positive steps states can take to attract companies and, at the same time, improve patient access to life-enhancing technologies,”
Growth of the medical technology industry tends to center around clusters of excellence, in which start-ups generate technologies of the future, medical centers and universities contribute ideas and trained personnel, and larger firms interact with the start-ups to help transform new products into large scale sales and employment.
The state-based agenda is focused on creating a more favorable business climate and increased predictability for promising early-stage companies as well as established firms. The agenda proposes specific recommendations under three broad policy areas including: state taxes, business assistance programs, and coverage and reimbursement policies. Specific recommendations include:
Research and development tax credits and state-run venture capital funds should be established by states that have not already done so, providing a significant boost for start-ups in particular.
States should consider tax credits to mitigate the impact of the federal medical device excise tax, which took effect on Jan. 1 since the federal tax will have a negative impact on industry employment as well as research and development.
Work force training grants should be provided to meet manufacturers’
Reimbursement policies under state Medicaid plans, as well as state employee insurance and workers’ compensation programs, should ensure patients have timely and predictable access to innovative medical technologies.
“AdvaMed’s State Medical Technology Competitiveness Agenda will help states retain and attract the kind of high-paying, high tech jobs that will fuel America’s economy in the 21st century,” Ubl said. “We look forward to working with SMTA and state policymakers to implement these proposals and ensure the U.S. retains its competitive edge in medical innovation,”
“New York is one of the leading states for business and research in the bioscience and medical technology industry,” said Jessica Crawford, president of MedTech. “Our focus on benefits that will make our Bio/Med companies competitive on a national and global scale will also contribute to business growth, which ultimately leads to more jobs and economic growth.”
Full details of the AdvaMed State Medical Technology Competitiveness Agenda and additional background information on the Agenda can be found at http://advamed.org/
AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit http://www.advamed.org.
MedTech is an active association of pharmaceutical, biotech, and medical technology companies, their suppliers and service providers, and research universities. We boost the growth and prosperity of our members by connecting them for collaboration, offering educational programs, sharing news and information, and advocating for the industry with government and leaders. For more information, visit http://www.medtech.org.